Article (Scientific journals)
Inhibiteurs des calcifications cardiovasculaires.
Liabeuf, Sophie; DELANAYE, Pierre; Cavalier, Etienne et al.
2015In Annales de Biologie Clinique, 73 (3), p. 315-22
Peer Reviewed verified by ORBi
 

Files


Full Text
ABC_1047_Liabeuf_Massy.pdf
Author preprint (409.95 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
calcium sensing receptor; fetuin A; matrix Gla protein; pyrophosphate; vascular calcification
Abstract :
[en] Vascular calcification is a marker of cardiovascular risk increase. Age and specific disease such as diabetes or chronic kidney disease are important factors for calcification genesis. Vascular calcification process is a complex phenomenon, involving several activators and inhibitors factors. Indeed, recent works related to in vitro and in vivo experimental studies have led to a better understanding of calcification process and identification of molecules able to modulate this system. This revue will summarize some of these molecules with a particular interest of those with therapeutic relevance. We will present: i) calcium sensing receptor and its modulation by cinacalcet; ii) pyrophosphate supplementation; iii) fetuin A and overall propensity serum test for calcification and finally; iv) matrix-Gla-protein and the use of vitamin K to prevent vascular calcification progression.
Disciplines :
Laboratory medicine & medical technology
Author, co-author :
Liabeuf, Sophie
DELANAYE, Pierre  ;  Centre Hospitalier Universitaire de Liège - CHU > Service de néphrologie
Cavalier, Etienne  ;  Université de Liège > Département de pharmacie > Chimie médicale
Guerin, Alain
Kamel, Said
Massy, Ziad A.
Language :
French
Title :
Inhibiteurs des calcifications cardiovasculaires.
Alternative titles :
[en] Cardiovascular calcification inhibitors
Publication date :
June 2015
Journal title :
Annales de Biologie Clinique
ISSN :
0003-3898
eISSN :
1950-6112
Publisher :
John Libbey Eurotext, France
Volume :
73
Issue :
3
Pages :
315-22
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Groupe de travail : J. Arnaud and Ph. Zaoui, CHU Grenoble ; M.C. Carlier, M. Laville and D. Fouque CHU Lyon ; E. Cavalier and P. Delanaye, CHU Sart-Tilaman Liège ; J.P. Cristol and A.S. Bargnoux, CHU Montpellier ; S. Kamel, Université de Picardie, Z. Massy, Ambroise Paré et UVSQ Paris ; et Inserm U-1088 et Université de Picardie, D. Prié, P. Urena-Torres and J.C. Souberbielle, Inserm/Université U 845 ; A. Boutten, APHP - GH Paris Nord Val de Seine ; A. Guérin, CH de Manhes ; T. Hannedouche, CHU Strasbourg, Ph. Brunet CHU Marseille ; G. Jean, Nephrocare Tassin-Charcot ; M.H. Lafage-Proust CHU St Etienne ; G. London, Inserm U970 ; L. Mercadal, Pitié Salpêtrière Paris ; L. Pieroni, CH Avignon
Available on ORBi :
since 14 September 2016

Statistics


Number of views
43 (0 by ULiège)
Number of downloads
5 (0 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
0
OpenCitations
 
1

Bibliography


Similar publications



Contact ORBi